Recombinant Epidermal Growth Factor Receptor (EGFR)    
    
ErbB-1; ErbB1; ER1; ERB-B1; MENA; HER1; Erythroblastic Leukemia Viral(v-Erb-B)oncogene Homolog,Avian; Proto-oncogene c-ErbB-1; Receptor tyrosine-protein kinase erbB-1
Overview
Properties
- Product No.RPA757Hu02
 - Organism SpeciesHomo sapiens (Human) Same name, Different species.
 - 
                                Applications
                                Positive Control; Immunogen; SDS-PAGE; WB.
If bio-activity of the protein is needed, please check active protein.
Research use only - DownloadInstruction Manual
 - CategoryCD & Adhesion moleculeTumor immunity
 
- Source Prokaryotic expression, Host E.coli
 - Endotoxin Level<1.0EU per 1µg (determined by the LAL method)
 - Subcellular LocationMembrane
 - Molecular Mass 39.9kDa, Accurate 44kDa(Analysis of differences refer to the manual)
 - Residues & TagsHis888~Ala1210 with N-terminal His Tag
 - Buffer FormulationPBS, pH7.4, containing 0.01% SKL, 5% Trehalose.
 - Traits Freeze-dried powder, Purity > 80%
 - Isoelectric Point5.2
 
    Share your citation
    Upload your experimental result
    Review
    Leave a message
    
        
    
        
        
    
        
        
            
                
                
            
            
                
                
            
            
                
                
            
            
            
                
            
        
    
    
         
        
            
                
                
            
            
                
                
                
            
            
            
                
            
        
    
    
         
        
            
                
                
                
                
            
            
                
            
            
                
            
        
      
    
         
        
            
                
            
        
    
                    
        Loading...
        
    Sign into your account
Share a new citation as an author
Upload your experimental result
Review
                
                 Please attach serial No. on instruction manual
                
            
            
            
Contact us
Please fill in the blank.
                Name*
                
            
            
                Organization
                
            
            
                Address
                
            
            
                E-mail address*
                
            
            
                Telephone
                
            
            
                Inquiry*
                
            
            
                Verification code*
                
                
            
            
            Sequence
                                        
                                    Usage
Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
Storage
Avoid repeated freeze/thaw cycles. Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months.
Stability
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.
Increment services
- 
                
                    Endotoxin Removal Kit
                                 - 
                
                    BCA Protein Quantification Kit
                                 - 
                
                    Protein Labeling Customized Service
                                 - 
                
                    Molecular Mass Marker for Protein
                                 - 
                
                    Recombinant Protein Customized Service
                                 - 
                
                    Monoclonal Antibody Customized Service
                                 - 
                
                    Polyclonal Antibody Customized Service
                                 - 
                
                    Protein Activity Test Experiment Service
                                 - 
                
                    Immunoprecipitation (IP) Experiment Service
                                 - 
                
                    Buffer
                                 - 
                
                    Endotoxin Removal Kit II
                                 - 
                
                    Real Time PCR Experimental Service
                                 - 
                
                    Spike RBD Protein (S-RBD)
                                 - 
                
                    Protein G
                                 - 
                
                    Protein A
                                 
Citations
- Nimotuzumab combined with gemcitabine and cisplatin as second-line chemotherapy for advanced non-small-cell lung cancerWiley: source
 - Increased Epidermal Growth Factor Receptor (EGFR) Associated with Hepatocyte Growth Factor (HGF) and Symptom Severity in Children with Autism …Pubmed:25249767
 - GC1118, an anti-EGFR antibody with a distinct binding epitope and superior inhibitory activity against high-affinity EGFR ligandsPubMed: 26586721
 - LINC01225 promotes occurrence and metastasis of hepatocellular carcinoma in an epidermal growth factor receptor-dependent pathwayPubmed:26938303
 - Microfluidic immunosensor based on mesoporous silica platform and CMK-3/poly-acrylamide-co-methacrylate of dihydrolipoic acid modified gold electrode for cancer biomarker detection.pubmed:28335979
 - EGFR detection in extracellular vesicles of breast cancer patients through immunosensor based on silica-chitosan nanoplatformDoi: 10.1016/j.talanta.2018.10.016
 - Design, synthesis, molecular docking and biological activity evaluation of some novel indole derivatives as potent anticancer active agents and apoptosis inducersPubmed: 30665034
 - Novel thienopyrimidine derivatives as dual EGFR and VEGFR-2 inhibitors: design, synthesis, anticancer activity and effect on cell cycle profilePubmed: 30919701
 - Design and synthesis of new benzoxazole/benzothiazole-phthalimide hybrids as antitumor-apoptotic agents
 - Synthesis and anticancer activity of bis-benzo [d][1, 3] dioxol-5-yl thiourea derivatives with molecular docking studyPubmed: 31288134
 - Evaluation of the Effect Derived from Silybin with Vitamin D and Vitamin E Administration on Clinical, Metabolic, Endothelial Dysfunction, Oxidative Stress Parameters …Pubmed: 31737175
 - Patient-derived xenograft (PDX) models of colorectal carcinoma (CRC) as a platform for chemosensitivity and biomarker analysis in personalized medicinePubmed: 33212364
 - Association between Serum Epidermal Growth Factor Receptor and Cyclooxygenase-2 Levels in Patients with Non-small Cell Carcinoma of Lung
 - Synthesis, EGFR-TK inhibition and anticancer activity of new quinoxaline derivatives
 - Humoral immune response to epidermal growth factor receptor in lung cancer33495907
 - Pyrazolo[3,4-d]pyrimidine-based dual EGFR T790M/HER2 inhibitors: Design, synthesis, structure¨Cactivity relationship and biological activity as potential antitumor and anticonvulsant agents33545637
 - Design, synthesis, antiproliferative evaluation, and molecular docking study of new quinoxaline derivatives as apoptotic inducers and EGFR inhibitors
 - Emitter–Quencher Pair of Single Atomic Co Sites and Monolayer Titanium Carbide MXenes for Luminol Chemiluminescent Reactions34914377
 - Discovery of new pyrimido [5, 4-c] quinolines as potential antiproliferative agents with multitarget actions: Rapid synthesis, docking, and ADME studiesPubmed:35219045
 
